Differentiated Antiretroviral Therapy Distribution Models: Enablers and Barriers to Universal HIV Treatment in South Africa, Uganda, and Zimbabwe.


Journal

The Journal of the Association of Nurses in AIDS Care : JANAC
ISSN: 1552-6917
Titre abrégé: J Assoc Nurses AIDS Care
Pays: United States
ID NLM: 9111870

Informations de publication

Date de publication:
Historique:
pubmed: 29 5 2019
medline: 17 9 2020
entrez: 29 5 2019
Statut: ppublish

Résumé

Emerging HIV treatment distribution models across sub-Saharan Africa seek to overcome barriers to attaining antiretroviral therapy and to strengthen adherence in people living with HIV. We describe enablers, barriers, and benefits of differentiated treatment distribution models in South Africa, Uganda, and Zimbabwe. Data collection included semistructured interviews and focus group discussions with 163 stakeholders from policy, program, and patient levels. Four types of facility-based and 3 types of community-based models were identified. Enablers included policy, leadership, and guidance; functional information systems; strong care linkages; steady drug supply; patient education; and peer support. Barriers included insufficient drug supply, stigma, discrimination, and poor care linkages. Benefits included perceived improved adherence, peer support, reduced stigma and discrimination, increased time for providers to spend with complex patients, and travel and cost savings for patients. Differentiated treatment distribution models can enhance treatment access for patients who are clinically stable.

Identifiants

pubmed: 31135515
doi: 10.1097/JNC.0000000000000097
pmc: PMC6756295
doi:

Substances chimiques

Anti-HIV Agents 0
Anti-Retroviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e132-e143

Références

Cochrane Database Syst Rev. 2013 Jun 27;(6):CD009987
pubmed: 23807693
Trop Med Int Health. 2010 Dec;15(12):1413-20
pubmed: 20958897
PLoS One. 2010 Sep 21;5(9):e12888
pubmed: 20877631
Trop Med Int Health. 2014 Aug;19(8):968-77
pubmed: 24889337
AIDS Res Treat. 2012;2012:574656
pubmed: 22461980
BMC Public Health. 2014 Apr 15;14:364
pubmed: 24735550
AIDS Care. 2018 Aug;30(8):1010-1016
pubmed: 29471667
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21644
pubmed: 28770589
AIDS Res Treat. 2012;2012:749718
pubmed: 22577527
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):594-600
pubmed: 19298993
Bull World Health Organ. 2008 Jul;86(7):559-67
pubmed: 18670668
BMC Health Serv Res. 2012 Jul 09;12:194
pubmed: 22776682
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
J Infect Dis. 2007 Dec 1;196 Suppl 3:S464-8
pubmed: 18181695
Ann Intern Med. 2011 Aug 16;155(4):209-16
pubmed: 21768555
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21648
pubmed: 28770597
Psychol Health Med. 2015;20(4):488-94
pubmed: 25168720
BMC Health Serv Res. 2015 Nov 17;15:513
pubmed: 26577831
Int Health. 2013 Sep;5(3):169-79
pubmed: 24030268
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650
pubmed: 28770594

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH